Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration.
Jindal S, Pedersen DV, Gera N, Chandler J, Patel R, Neill A, Cone J, Zhang Y, Yuan CX, Millman EE, Carlin D, Puffer B, Sheridan D, Andersen GR, Tamburini P. Jindal S, et al. Among authors: millman ee. Mol Immunol. 2024 Jan;165:29-41. doi: 10.1016/j.molimm.2023.12.004. Epub 2023 Dec 23. Mol Immunol. 2024. PMID: 38142486 Free article.
Correction to: Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab.
Cammett TJ, Garlo K, Millman EE, Rice K, Toste CM, Faas SJ. Cammett TJ, et al. Among authors: millman ee. Mol Diagn Ther. 2023 Mar;27(2):281. doi: 10.1007/s40291-023-00643-4. Epub 2023 Mar 4. Mol Diagn Ther. 2023. PMID: 36870041 Free PMC article. No abstract available.
Exploratory Prognostic Biomarkers of Complement-Mediated Thrombotic Microangiopathy (CM-TMA) in Adults with Atypical Hemolytic Uremic Syndrome (aHUS): Analysis of a Phase III Study of Ravulizumab.
Cammett TJ, Garlo K, Millman EE, Rice K, Toste CM, Faas SJ. Cammett TJ, et al. Among authors: millman ee. Mol Diagn Ther. 2023 Jan;27(1):61-74. doi: 10.1007/s40291-022-00620-3. Epub 2022 Nov 4. Mol Diagn Ther. 2023. PMID: 36329366 Free PMC article. Clinical Trial.
Endosome sorting of beta 2-adrenoceptors is GRK5 independent.
Millman EE, Rosenfeld JL, Vaughan DJ, Nguyen J, Dai W, Alpizar-Foster E, Clark RB, Knoll BJ, Moore RH. Millman EE, et al. Br J Pharmacol. 2004 Jan;141(2):277-84. doi: 10.1038/sj.bjp.0705504. Epub 2003 Dec 22. Br J Pharmacol. 2004. PMID: 14691047 Free PMC article.
14 results